You are here

Arikayce

Insmed shares soar as PhIII lung disease study proves positive, pointing to quick FDA pitch

Endpoints

Tue, 09/5/17 - 10:16 pm

clinical trials

8 Biotech Events To Anticipate This Year: Part One

Seeking Alpha

Tue, 04/8/14 - 09:46 am

obeticholic acid

Intercept Pharmaceuticals